H.R. 4764 · 116th Congress
Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2020
- Stage
- Passed a chamber
- Sponsor
- Doris Matsui
- Introduced
- 2019-10-18
- Latest action
- 2020-12-14 · Message on Senate action sent to the House.
Subjects
Congressional oversight
Government studies and investigations
Health
Medical research
Health programs administration and funding
Advisory bodies
Research administration and funding
Blood and blood diseases
Organ and tissue donation and transplantation
Cell biology and embryology